| Detected | Trial | Change |
|---|---|---|
| 2026-08-06 | NCT07630649 Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With… |
Trial sites expanded: 4 -> 12 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07482176 | Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With… | Neovascular Age-Related Macular Degeneration (nAMD) | Recruiting |
| NCT06856577 | Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With… | Neovascular Age-Related Macular Degeneration (nAMD) | Active, Not Recruiting |
| Phase 2 | |||
| NCT07630649 | Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With… | Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD | Recruiting |
| NCT05536973 | Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular… | Neovascular Age-related Macular Degeneration | Active, Not Recruiting |
| Not specified | |||
| NCT05607810 | Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT) | Diabetic Macular Edema | Active, Not Recruiting |
| NCT04645212 | Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT] | Wet Age-related Macular Degeneration | Active, Not Recruiting |